Page last updated: 2024-10-27

fluorouracil and Cancer Pain

fluorouracil has been researched along with Cancer Pain in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Cancer Pain: Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vienot, A1
Beinse, G1
Louvet, C1
de Mestier, L1
Meurisse, A1
Fein, F1
Heyd, B1
Cleau, D1
d'Engremont, C1
Dupont-Gossart, AC1
Lakkis, Z1
Tournigand, C1
Bouché, O1
Rousseau, B1
Neuzillet, C1
Bonnetain, F1
Borg, C1
Vernerey, D1
Kim, SH1
Park, BS1
Kim, HS1
Kim, JH1

Reviews

1 review available for fluorouracil and Cancer Pain

ArticleYear
Synchronous quintuple primary gastrointestinal tract malignancies: Case report.
    World journal of gastroenterology, 2017, Jan-07, Volume: 23, Issue:1

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cancer

2017

Other Studies

1 other study available for fluorouracil and Cancer Pain

ArticleYear
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma.
    Journal of the National Cancer Institute, 2017, 10-01, Volume: 109, Issue:10

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Camptothecin; Cancer Pai

2017